Astros Th. Skuladottir

Astros Th. Skuladottir

Auto-generated profile, based on publicly available information

Astros Th. Skuladottir

DeCODE genetics/Amgen, Reykjavik, Iceland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
GBGyda Bjornsdottir
Gyda Bjornsdottir
LSLilja Stefansdottir
Lilja Stefansdottir
GTGudmar Thorleifsson
Gudmar Thorleifsson
PSPatrick Sulem
Patrick Sulem
KNKristjan Norland
Kristjan Norland
GCGO Consortium
GO Consortium
Back pain is a common and debilitating disorder with largely unknown underlying biology. Here we report a genome-wide association study of back pain using diagnoses assigned in clinical practice; dorsalgia (119,100 cases, 909,847 controls) and intervertebral disc disorder (IDD) (58,854 cases, 922,958 controls). We identify 41 variants at 33 loci. The most significant association (ORIDD = 0.92, P = 1.6 × 10−39; ORdorsalgia = 0.92, P = 7.2 × 10−15) is with a 3’UTR variant (rs1871452-T) in CHST3, encoding a sulfotransferase enzyme expressed in intervertebral discs. The largest effects on IDD are conferred by rare (MAF = 0.07 − 0.32%) loss-of-function (LoF) variants in SLC13A1, encoding a sodium-sulfate co-transporter (LoF burden OR = 1.44, P = 3.1 × 10−11); variants that also associate with reduced serum sulfate. Genes implicated by this study are involved in cartilage and bone biology, as well as neurological and inflammatory processes.

26 October 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
GBGyda Bjornsdottir
Gyda Bjornsdottir
MCMona Ameri Chalmer
Mona Ameri Chalmer
LSLilja Stefansdottir
Lilja Stefansdottir
ASAstros Th. Skuladottir
Astros Th. Skuladottir
GEGudmundur Einarsson
Gudmundur Einarsson
KSKari Stefansson
Kari Stefansson
Migraine is a complex neurovascular disease with a range of severity and symptoms, yet mostly studied as one phenotype in genome-wide association studies (GWAS). Here we combine large GWAS datasets from six European populations to study the main migraine subtypes, migraine with aura (MA) and migraine without aura (MO). We identified four new MA-associated variants (in PRRT2, PALMD, ABO and LRRK2) and classified 13 MO-associated variants. Rare variants with large effects highlight three genes. A rare frameshift variant in brain-expressed PRRT2 confers large risk of MA and epilepsy, but not MO. A burden test of rare loss-of-function variants in SCN11A, encoding a neuron-expressed sodium channel with a key role in pain sensation, shows strong protection against migraine. Finally, a rare variant with cis-regulatory effects on KCNK5 confers large protection against migraine and brain aneurysms. Our findings offer new insights with therapeutic potential into the complex biology of migraine and its subtypes.

7 October 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
ASAstros Th. Skuladottir
Astros Th. Skuladottir
GBGyda Bjornsdottir
Gyda Bjornsdottir
MNMuhammad Sulaman Nawaz
Muhammad Sulaman Nawaz
HPHannes Petersen
Hannes Petersen
SRSolvi Rognvaldsson
Solvi Rognvaldsson
KSKari Stefansson
Kari Stefansson
Vertigo is the leading symptom of vestibular disorders and a major risk factor for falls. In a genome-wide association study of vertigo (Ncases = 48,072, Ncontrols = 894,541), we uncovered an association with six common sequence variants in individuals of European ancestry, including missense variants in ZNF91, OTOG, OTOGL, and TECTA, and a cis-eQTL for ARMC9. The association of variants in ZNF91, OTOGL, and OTOP1 was driven by an association with benign paroxysmal positional vertigo. Using previous reports of sequence variants associating with age-related hearing impairment and motion sickness, we found eight additional variants that associate with vertigo. Although disorders of the auditory and the vestibular system may co-occur, none of the six genome-wide significant vertigo variants were associated with hearing loss and only one was associated with age-related hearing impairment. Our results uncovered sequence variants associating with vertigo in a genome-wide association study and implicated genes with known roles in inner ear development, maintenance, and disease.

13 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAlice Braun
Alice Braun
SSSudhanshu Shekhar
Sudhanshu Shekhar
DLDaniel Levey
Daniel Levey
PSPeter Straub
Peter Straub
JKJulia Kraft
Julia Kraft
SRStephan Ripke
Stephan Ripke
Myasthenia gravis (MG) is a rare autoantibody-mediated disease affecting the neuromuscular junction. We performed a genome-wide association study of 5708 MG cases and 432,028 controls of European ancestry and a replication study in 3989 cases and 226,643 controls provided by 23andMe Inc. We identified 12 independent genome-wide significant hits (P < 5e−8) across 11 loci. Subgroup analyses revealed two of these were associated with early-onset (at age <50) and four with late-onset MG (at age ≥ 50). Imputation of human leukocyte antigen alleles revealed inverse effect sizes for late- and early-onset, suggesting a potential modulatory influence on the time of disease manifestation. We assessed the performance of polygenic risk scores for MG, which significantly predicted disease status in an independent target cohort, explaining 4.21% of the phenotypic variation (P = 5.12e−9). With this work, we aim to enhance our understanding of the genetic architecture of MG.

24 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ASAstros Th. Skuladottir
Astros Th. Skuladottir
GBGyda Bjornsdottir
Gyda Bjornsdottir
EFEgil Ferkingstad
Egil Ferkingstad
GEGudmundur Einarsson
Gudmundur Einarsson
LSLilja Stefansdottir
Lilja Stefansdottir
DCDBDS Genetic Consortium
DBDS Genetic Consortium
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy and has a largely unknown underlying biology. In a genome-wide association study of CTS (48,843 cases and 1,190,837 controls), we found 53 sequence variants at 50 loci associated with the syndrome. The most significant association is with a missense variant (p.Glu366Lys) in SERPINA1 that protects against CTS (P = 2.9 × 10−24, OR = 0.76). Through various functional analyses, we conclude that at least 22 genes mediate CTS risk and highlight the role of 19 CTS variants in the biology of the extracellular matrix. We show that the genetic component to the risk is higher in bilateral/recurrent/persistent cases than nonrecurrent/nonpersistent cases. Anthropometric traits including height and BMI are genetically correlated with CTS, in addition to early hormonal-replacement therapy, osteoarthritis, and restlessness. Our findings suggest that the components of the extracellular matrix play a key role in the pathogenesis of CTS.

26 April 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
ASAstros Th. Skuladottir
Astros Th. Skuladottir
LSLilja Stefansdottir
Lilja Stefansdottir
GHGisli H. Halldorsson
Gisli H. Halldorsson
OSOlafur A. Stefansson
Olafur A. Stefansson
ABAnna Bjornsdottir
Anna Bjornsdottir
KSKari Stefansson
Kari Stefansson
Essential tremor (ET) is a prevalent neurological disorder with a largely unknown underlying biology. In this genome-wide association study meta-analysis, comprising 16,480 ET cases and 1,936,173 controls from seven datasets, we identify 12 sequence variants at 11 loci. Evaluating mRNA expression, splicing, plasma protein levels, and coding effects, we highlight seven putative causal genes at these loci, including CA3 and CPLX1. CA3 encodes Carbonic Anhydrase III and carbonic anhydrase inhibitors have been shown to decrease tremors. CPLX1, encoding Complexin-1, regulates neurotransmitter release. Through gene-set enrichment analysis, we identify a significant association with specific cell types, including dopaminergic and GABAergic neurons, as well as biological processes like Rho GTPase signaling. Genetic correlation analyses reveals a positive association between ET and Parkinson’s disease, depression, and anxiety-related phenotypes. This research uncovers risk loci, enhancing our knowledge of the complex genetics of this common but poorly understood disorder, and highlights CA3 and CPLX1 as potential therapeutic targets.